The Advisory Committee on Immunization Practices (ACIP) convened its first public meeting since President Trump's inauguration without signs of administrative interference. Key decisions included expanding meningococcal vaccine options and adjusting RSV vaccine eligibility to individuals aged 50-59 with specific risk factors. A recommendation for chikungunya vaccines for certain travelers and lab workers was also made. The meeting involved extensive discussions on various vaccines, highlighting transparency amidst the evolving political context and public health challenges, including measles outbreaks and COVID-19.
"I am encouraged that the proceedings of ACIP have resumed, giving the American public a window into the future of our nation's vaccine policy in a time of great uncertainty."
"The committee had been scheduled to meet in February, but the event was postponed shortly after the confirmation of Robert F. Kennedy Jr. as secretary of the Department of Health and Human Services..."
Collection
[
|
...
]